Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Bruna Araújo, Rita Caridade-Silva, Carla Guedes, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2908-2908
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms
Ming‐Chang Chiang, Tsung‐Yu Tsai, Chieh-Ju Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6328-6328
Open Access | Times Cited: 78
Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 37
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
Zahra Razavi, Seyed Sina Alizadeh, F. S. Razavi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125186-125186
Open Access | Times Cited: 1
The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Viviana A. Ruiz‐Pozo, Rafael Tamayo‐Trujillo, Santiago Cadena-Ullauri, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3585-3585
Open Access | Times Cited: 26
Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration
Nasir Uddin Mahbub, Md Minarul Islam, Seong‐Tshool Hong, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 11
PPARs and Their Neuroprotective Effects in Parkinson’s Disease: A Novel Therapeutic Approach in α-Synucleinopathy?
Isaac Pérez-Segura, Alberto Santiago-Balmaseda, Luis Daniel Rodríguez-Hernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3264-3264
Open Access | Times Cited: 16
3-N-butylphthalide attenuates neuroinflammation in rotenone-induced Parkinson’s disease models via the cGAS-STING pathway
Yuqian Liu, Ruonan Duan, Peizheng Li, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 6
A review of MPTP-induced parkinsonism in adult zebrafish to explore pharmacological interventions for human Parkinson’s disease
E. E. Bagwell, Jessica Larsen
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 6
Neuroinflammation: A Critical Factor in Neurodegenerative Disorders
Zahieh Suleiman Khoury, Fatima Sohail, Jada Wang, et al.
Cureus (2024)
Open Access | Times Cited: 5
Transcranial Direct Current Stimulation for Improvement of Neurotransplantation Outcomes in Rats with 6-Hydroxydopamine-Induced Parkinsonism
А. V. Stavrovskaya, Д. Н. Воронков, Ivan A. Potapov, et al.
Annals of Clinical and Experimental Neurology (2025) Vol. 18, Iss. 4, pp. 44-54
Open Access
Ginsenosides Rg1, Rb1 and rare ginsenosides: promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
Mingchun Jiang, Jiaxin Chi, Yifan Qiao, et al.
Pharmacological Research (2025) Vol. 212, pp. 107578-107578
Open Access
A single-cell transcriptome analysis reveals astrocyte heterogeneity and identifies CHI3L1 as a diagnostic biomarker in Parkinson's disease
Zhongying Gong, Dan Guo, Yufeng Lin, et al.
Heliyon (2025), pp. e42051-e42051
Open Access
Factors responsible for alpha-Synuclein aggregation
Khuraijam Surjalal Singh, Rahul Verma, N. Okendro Singh, et al.
Progress in molecular biology and translational science (2025)
Closed Access
Advances in neural stem cells in aging and age-related neurodegenerative diseases
Rujia Zhong, Wenhao Huang, Chao Chen, et al.
Ageing and Neurodegenerative Diseases (2025) Vol. 5, Iss. 1
Open Access
Psychedelics in neuroinflammation: Mechanisms and therapeutic potential
Júnia L. de Deus, Juliana Marino Maia, Renato Nery Soriano, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111278-111278
Closed Access
Astaxanthin-loaded brain-permeable liposomes for Parkinson’s disease treatment via antioxidant and anti-inflammatory responses
Thuy-vi Nguyen, Shristi Khanal, Eun-Hee Lee, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
The Antioxidant Role of Aromatic Plant Extracts in Managing Neurodegenerative Diseases: A Comprehensive Review
Youyang Zhu, Miao Tian, Shiyu Lu, et al.
Brain Research Bulletin (2025), pp. 111253-111253
Open Access
Unraveling the role of neuregulin-mediated astrocytes-OPCs axis in the pathogenesis of age-related macular degeneration and Parkinson’s disease
Shuyan Zhang, Cheng Zhang, Yinjian Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Inflammatory hallmarks in 6-OHDA- and LPS-induced Parkinson's disease in rats
Zhanna Oliynyk, Mariia Rudyk, Taisa Dovbynchuk, et al.
Brain Behavior & Immunity - Health (2023) Vol. 30, pp. 100616-100616
Open Access | Times Cited: 13
Impact of sex on neuroimmune contributions to Parkinson’s disease
Mélanie Bourque, Marc Morissette, Denis Soulet, et al.
Brain Research Bulletin (2023) Vol. 199, pp. 110668-110668
Open Access | Times Cited: 12
Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson’s Disease
Talha M Siddiqui, Lokesh Kumar Bhatt
Neurochemical Research (2023) Vol. 48, Iss. 10, pp. 2925-2935
Open Access | Times Cited: 11
Parkinson’s Disease Dementia Patients: Expression of Glia Maturation Factor in the Brain
Ramasamy Thangavel, Harleen Kaur, Iuliia Dubova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1182-1182
Open Access | Times Cited: 3
Expression of G2019S LRRK2 in Rat Primary Astrocytes Mediates Neurotoxicity and Alters the Dopamine Synthesis Pathway in N27 Cells via Astrocytic Proinflammatory Cytokines and Neurotrophic Factors
Dong Hwan Ho, Hye Jung Kim, Daleum Nam, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4324-4336
Open Access | Times Cited: 3
B355252 Suppresses LPS-Induced Neuroinflammation in the Mouse Brain
Qingping He, Qi Qi, Gordon C. Ibeanu, et al.
Brain Sciences (2024) Vol. 14, Iss. 5, pp. 467-467
Open Access | Times Cited: 3
Glial Cultures Differentiated from iPSCs of Patients with PARK2-Associated Parkinson’s Disease Demonstrate a Pro-Inflammatory Shift and Reduced Response to TNFα Stimulation
Tatiana Gerasimova, Ekaterina Stepanenko, Lyudmila Novosadova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2000-2000
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top